Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
OBN
OBN
Activities:
Media
Research & Development
X
LinkedIn
Trending Articles
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Fasenra for EGPA: addressing unmet needs
Benralizumab could offer patients with EGPA more treatment options, while reducing dependency on oral corticosteroids
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Bristol Myers Squibb and Cellares partner to expand CAR-T manufacturing capabilities
Cellares will optimise and automate select Bristol Myers Squibb CAR-T cell therapies onto its high-throughput manufacturing program, the Cell Shuttle
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
New recruits at OBN
Bill Fleming and David Browning join board of the not-for-profit membership organisation supporting UK's life sciences companies, corporate partners and investors
Research & Development
BioForward - The 'Roadmap for Growth' Life Sciences Event
4 October 2018 | Conference | Birmingham, UK
OBN appoints three new directors
New members add considerable sector experience to the board, bringing legal, investment, commercial and general management expertise
Research & Development
Biotrinity 2016
25 - 27 April 2016, Conference, Novotel London West, London, UK
Research & Development
ABPI and OBN sign Memorandum of Understanding
To look for partnership initiatives to help build better public profile and understanding of all biosciences
OBN strengthens Board and Operations team
UK membership organisation has about 260 members
Research & Development
BioTrinity
12 - 14 May 2014, Conference, Novotel London West, UK
Subscribe now